CYP17A1 and prostate cancer: Subsequently, the complex model of CYP17A1-BDBM50061174 was constructed by similarity-based docking employing the crystal structure of CYP17A1 bound to abiraterone, a steroidal prostate cancer drug (PDB-ID: 3ruk, chain D) [34].